Target Details
| UniProt AC | P21802 |
|---|---|
| Gene Symbol | FGFR2 |
| Protein Name | Fibroblast growth factor receptor 2 |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF07679 (I-set) PF13927 (Ig_3) PF07714 (PK_Tyr_Ser-Thr) |
Summary
- Multi-target molecules 2,130
- Clinical molecules 64
- Avg pChEMBL 7.82
KEGG Pathways (13)
- Calcium signaling pathway
- Central carbon metabolism in cancer
- EGFR tyrosine kinase inhibitor resistance
- Endocytosis
- Gastric cancer
- MAPK signaling pathway
- PI3K-Akt signaling pathway
- Pathways in cancer
- Prostate cancer
- Rap1 signaling pathway
- Ras signaling pathway
- Regulation of actin cytoskeleton
- Signaling pathways regulating pluripotency of stem cells
Associated Diseases (12)
- Antley-Bixler syndrome
- Apert syndrome
- Beare-Stevenson syndrome
- Bent bone dysplasia syndrome
- Crouzon syndrome
- Gastric cancer
- Jackson-Weiss syndrome
- Lacrimo-auriculo-dento-digital syndrome
- Pfeiffer syndrome
- Saethre-Chotzen syndrome
- Scaphocephaly, maxillary retrusion, and impaired intellectual development
- Syndromic craniosynostoses
Active Molecules (2,130)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
VCNJSFBAEBDCKK
|
8.3 | IC50 | 5 | — | |
VEFIZLZPHCCAQO
|
8.3 | IC50 | 3 | — | |
VQQPYYDKDDVKFZ
|
8.3 | IC50 | 5 | — | |
AIVBMTJXLHCJTQ
|
8.3 | IC50 | 5 | — | |
BBPYINKOTXNMRZ
|
8.3 | IC50 | 3 | — | |
BYEGVFRRTLAAQA
|
8.3 | IC50 | 2 | — | |
DVBMTJCMGPJACG
|
8.3 | IC50 | 5 | — | |
JRZBGTIYYHVJEO
|
8.3 | IC50 | 5 | — | |
NAFMCDLLMRKVNJ
|
8.3 | IC50 | 5 | — | |
QUVMICMHDQTVPB
|
8.3 | IC50 | 5 | — | |
SADVQUINRBCGFP
|
8.3 | IC50 | 7 | — | |
VIADTQYJXCPMEC
|
8.3 | IC50 | 5 | — | |
VSLNXMYUGRCLGS
|
8.3 | IC50 | 2 | — | |
WUUFTYPLVUNRIX
|
8.3 | IC50 | 5 | — | |
AGZXLIWBGAGZKW
|
8.3 | IC50 | 3 | — | |
ANTLFBMPTFHLKW
|
8.3 | IC50 | 3 | — | |
ANTLFBMPTFHLKW
|
8.3 | IC50 | 3 | — | |
CWPOQIGIHQYRNF
|
8.3 | IC50 | 3 | — | |
DKRZSFVZVVDUSO
|
8.3 | IC50 | 3 | — | |
HIDXCLAHVYKPCQ
|
8.3 | IC50 | 4 | — | |
IUQUAYSCBOOCOQ
|
8.3 | IC50 | 3 | — | |
JEBDREWJGILFIZ
|
8.3 | IC50 | 3 | — | |
JEDTURAIMNGEAI
|
8.3 | IC50 | 3 | — | |
JTSGAAOXUAIUDH
|
8.3 | IC50 | 3 | — | |
JWBKKCJZIDXHLG
|
8.3 | IC50 | 3 | — | |
KDFJDPRUNMUDND
|
8.3 | IC50 | 3 | — | |
KPDFFUWYNAEXCW
|
8.3 | IC50 | 3 | — | |
LBHGMHQDOQYTKT
|
8.3 | IC50 | 5 | — | |
LLPARKRXPDOMLJ
|
8.3 | IC50 | 5 | — | |
LLQNTDNLUGJXOW
|
8.3 | IC50 | 3 | — | |
MBGSKLWXWZBIRH
|
8.3 | IC50 | 3 | — | |
NACNRDLFKYYUNU
|
8.3 | IC50 | 3 | — | |
ONAZMIGCNRUYHT
|
8.3 | IC50 | 5 | — | |
OTYCSVIUOLUDPH
|
8.3 | IC50 | 3 | — | |
OVGRJRAGUWXTCO
|
8.3 | IC50 | 4 | — | |
OWLHHVGNWXMBFF
|
8.3 | IC50 | 2 | — | |
QIEVSBKOXPAREF
|
8.3 | IC50 | 5 | — | |
QTQBJRCBSLLTBA
|
8.3 | IC50 | 3 | — | |
QTQBJRCBSLLTBA
|
8.3 | IC50 | 3 | — | |
QYOSWBKWDQWBJG
|
8.3 | IC50 | 3 | — | |
RFXLZLOSWGJUJY
|
8.3 | IC50 | 5 | — | |
RREXRPSTGDCVNA
|
8.3 | Kd | 3 | — | |
TUKVBIHBLUMARN
|
8.3 | IC50 | 3 | — | |
VQVRLEDWFWGXCH
|
8.3 | IC50 | 5 | — | |
WOMBJJKPVIDFFI
|
8.3 | IC50 | 5 | — | |
WPVIYTSQVGVPEE
|
8.3 | IC50 | 3 | — | |
XHCHGZHSYDYRKE
|
8.3 | IC50 | 3 | — | |
XSDFUOBWKCWNGD
|
8.3 | IC50 | 3 | — | |
XSQABTCRYMWCRL
|
8.3 | IC50 | 3 | — | |
YEKLQWUGOHZIQV
|
8.3 | IC50 | 5 | — |